You are here
- Home
- Drug Products
- All Drug Products
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
- Disease
- Cancer and Infection Research Area
- Generic Name
- MEDI-551
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D2850C00001
- Study Id
- D2850C00001
- ClinicalTrials.gov ID
- NCT01377116
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
